Related Experiment Video
Updated: Oct 26, 2025

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
ZNRD1-AS1 knockdown alleviates malignant phenotype of retinoblastoma through miR-128-3p/BMI1 axis
Guanghua Yang1, Chen Zeng1, Yang Liu2
1First Department of Oncology, Zhumadian Central Hospital Zhumadian, Henan, China.
Background:
ZNRD1-AS1 plays an important role in liver cancer, endometrial cancer and other diseases. However, the relationship between ZNRD1-AS1 and retinoblastoma has not been studied in detail. This study aimed to determine the role of ZNRD1-AS1 in retinoblastoma.
Methods:
Differentially expressed genes in retinoblastoma downloaded from GEO database were identified by Limma package, and the expression and cell location of ZNRD1-AS1 were detected by real-time quantitative PCR (RT-qPCR). The relationships between miR-128-3p and two genes (ZNRD1-AS1 and BMI1) were analyzed by bioinformatics and dual-luciferase assay. After manipulating the expressions of ZNRD1-AS1, miR-128-3p and BMI1, cell viability, tube length, migration, invasion and the protein expressions (PCNA, E-Cadherin, N-Cadherin) of retinoblastoma cells were determined by cell counting kit-8 (CCK-8), tube formation, transwell and Western blot assays, respectively. Subcutaneous transplantation tumor assay, immunohistochemistry, and RT-qPCR were applied to verify the functions of the target gene in vivo.
Results:
ZNRD1-AS1 was up-regulated in the cytoplasm of retinoblastoma and regulated BMI1 via sponging miR-128-3p. ZNRD1-AS1 knockdown alleviated the malignant phenotype (viability, tube length, migration and invasion) of retinoblastoma cells, reduced tumor volume and weight, and inhibited BMI1 and CD34 expressions. Different from miR-128-3p mimic, miR-128-3p inhibitor promoted malignant phenotype of retinoblastoma cells, and partially reversed the inhibitory effect of siZNRD1-AS1. MiR-128-3p mimic down-regulated BMI1, PNCA, N-Cadherin expressions, and up-regulated p16 and E-Cadherin expressions. The regulatory effect of miR-128-3p was partially reversed by BMI1.
Conclusion:
ZNRD1-AS1, acting as a "sponge" of miR-128-3p, up-regulates BMI1, thereby promoting the progression of retinoblastoma.
Insights
Long non-coding RNA ZNRD1-AS1 promotes retinoblastoma progression by sponging miR-128-3p and up-regulating BMI1. Knockdown of ZNRD1-AS1 inhibits retinoblastoma cell malignancy and tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- ZNRD1-AS1 is implicated in various cancers, but its role in retinoblastoma remains unclear.
- Understanding ZNRD1-AS1's function is crucial for developing novel retinoblastoma therapies.
Purpose of the Study:
- To investigate the role and mechanism of ZNRD1-AS1 in retinoblastoma progression.
- To explore the regulatory relationship between ZNRD1-AS1, miR-128-3p, and BMI1 in retinoblastoma.
Main Methods:
- Differential gene expression analysis using GEO database and Limma package.
- RT-qPCR, dual-luciferase assay, and Western blot to analyze gene expression and interactions.
- In vitro cell assays (viability, migration, invasion) and in vivo tumor xenograft models to assess functional impact.
Main Results:
- ZNRD1-AS1 is upregulated in retinoblastoma cytoplasm and acts as a sponge for miR-128-3p, leading to BMI1 upregulation.
- ZNRD1-AS1 knockdown suppressed retinoblastoma cell malignancy and tumor growth, inhibiting BMI1 and CD34 expression.
- MiR-128-3p mimic reversed the effects of ZNRD1-AS1 knockdown, while BMI1 partially reversed miR-128-3p's regulatory effects.
Conclusions:
- ZNRD1-AS1 promotes retinoblastoma progression by sponging miR-128-3p and upregulating BMI1.
- ZNRD1-AS1 serves as a potential therapeutic target for retinoblastoma.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules
MicroRNAs
MicroRNAs
Abnormal Proliferation

